Home/Filings/3/0000899243-21-043985
3//SEC Filing

UNITED BIOMEDICAL INC 3

Accession 0000899243-21-043985

CIK 0001851657other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 4:58 PM ET

Size

8.4 KB

Accession

0000899243-21-043985

Insider Transaction Report

Form 3
Period: 2021-11-10
Holdings
  • Class A common stock

    51,338,366
  • Warrant

    (indirect: See Note)
    Class A common stock
  • Series A preferred stock

    (indirect: See Note)
    Class A common stock
  • Series A preferred stock

    Class A common stock
Footnotes (4)
  • [F1]Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.
  • [F2]The 384,410 shares of Series A preferred stock will convert into 247,050 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock.
  • [F3]The 6,554,643 shares of Series A preferred stock will convert into 4,212,495 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock.
  • [F4]Represents 1,928,020 shares of Class A common stock underlying a warrant. The warrant is currently exercisable and has an exercise price of $12.45.

Issuer

Vaxxinity, Inc.

CIK 0001851657

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0000896839

Filing Metadata

Form type
3
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:58 PM ET
Size
8.4 KB